Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;35(5):3565-3576.
doi: 10.1007/s10895-024-03771-0. Epub 2024 Jun 12.

Fluorescent Nitrogen-doped Carbon Dots-based Turn-off Sensor for Bilirubin

Affiliations

Fluorescent Nitrogen-doped Carbon Dots-based Turn-off Sensor for Bilirubin

Aswathy A O et al. J Fluoresc. 2025 May.

Abstract

Bilirubin (BR), a heme protein produced from breakdown of haemoglobin is present in aged red blood cells; whose abnormal concentration is associated with diseases like hyperbilirubinemia, coronary disease, iron deficiency, and so on. Herein, we have synthesized a selective, sensitive, and low-cost sensing platform using fluorescent nitrogen doped carbon dots (NCDs), prepared from precursors; citric acid and urea via a simple microwave-assisted method. The emission at 444 nm on excitation with 360 nm was well quenched in presence of BR suggesting a direct turn-off detection for BR. Characterization of developed probe was done by UV-Visible absorption studies, photoluminescence studies, SEM, TEM, ATR-FTIR, XPS, and DLS analysis. BR was detected with a Limit of Detection (LoD) and Limit of Quantification (LoQ) of 0.32 µM and 1.08 µM respectively. NCDs exhibited excellent selectivity and sensitivity towards BR in the presence of co-existing biomolecules and ions. Practical feasibility was checked by paper-strip-based sensing of BR and spiked real human samples were used for conducting real sample analysis.

Keywords: Bilirubin; Fluorescence sensing; Hyperbilirubinemia; Inner filter effect; Jaundice.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical Approval: The experiments were done following the Indian Council of Medical Research (ICMR) ethical standards and were approved by the University level Human Ethical Committee order no (ULECRIHS/UOK/2019/48, University of Kerala, Thiruvananthapuram). All the healthy volunteers who donated the blood samples were provided consent to participate and publish the result. Competing Interests: The authors declare no competing interests. Supporting Information: Additional supporting information can be found online in the supporting information section at the end of this article.

Similar articles

Cited by

References

    1. Tenhunen R, Marver HS, Schmid R, Oxygenase MH (1969) Characterization of the enzyme. J Biol Chem 244:6388–6394. https://doi.org/10.1016/S0021-9258(18)63477-5 - DOI - PubMed
    1. Hayaishi O, Nozaki M (1979) Nature and mechanisms of oxygenases. Science 164(1969):389–396. https://doi.org/10.1126/SCIENCE.164.3878.389/ASSET/E4257877-7D4D-4DB9-B4... - DOI
    1. Ndabakuranye JP, Li S, Burchall G, Fox K, Piva T, Xu Z, Kavehei O, Prawer S, Ahnood A (2022) 70 years of bilirubin sensing: towards the point-of- care bilirubin monitoring in cirrhosis and hyperbilirubinemia. Sens Diagnostics 1:932–954. https://doi.org/10.1039/d2sd00033d - DOI
    1. Adin CA (2021) Bilirubin as a Therapeutic Molecule: Challenges and Opportunities. Antioxidants 10 (2021) 1536. https://doi.org/10.3390/ANTIOX10101536 - DOI - PubMed - PMC
    1. Patra SK, Mandal AK, Pal MK (1999) State of aggregation of bilirubin in aqueous solution: principal component analysis approach. J Photochem Photobiol Chem 122:23–31. https://doi.org/10.1016/S1010-6030(98)00465-1 - DOI

LinkOut - more resources